Tarsus Pharmaceuticals, Inc. [TARS] has reported $17.4 million in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $135.9 million.
Based in Irvine, California, Tarsus Pharmaceuticals, Inc. operates in the Manufacturing sector.